GS
RMD icon

GTS Securities’s ResMed RMD Stock Holding History

GTS Securities’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$311K Buy
1,385
+4
+0.3% +$997 0.01% 1066
2025
Q4 		$333K Buy
1,381
+550
+66% +$141K 0.01% 1007
2025
Q3 		$227K Sell
831
-634
-43% -$173K 0.01% 1209
2025
Q2 		$378K Sell
1,465
-455
-24% -$109K 0.02% 792
2025
Q1 		$430K Buy
+1,920
New +$448K 0.02% 762
2024
Q4 		– Sell
-2,961
Closed -$723K – 3457
2024
Q3 		$723K Sell
2,961
-4,060
-58% -$907K ﹤0.01% 2469
2024
Q2 		$1.34M Buy
+7,021
New +$1.42M ﹤0.01% 1806
2024
Q1 		– Sell
-22,324
Closed -$4.09M – 4329
2023
Q4 		$3.84M Buy
+22,324
New +$3.43M 0.01% 1188

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GTS Securities's RMD Position: Q1 2026 in Review

GTS Securities increased its ResMed (RMD) stake by 0.29% in Q1 2026, buying an estimated $997 and bringing the position to 1,385 shares worth $311K. The position accounts for 0.01% of the portfolio, ranked #1066.

GTS Securities first reported a position in RMD in Q4 2023 and has held it in 8 quarters since. The position peaked at $3.84M in Q4 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • GTS Securities held 1,385 shares of ResMed worth $311K as of Q1 2026.
  • GTS Securities bought 4 ResMed shares in Q1 2026, an estimated $997.
  • ResMed made up 0.01% of GTS Securities's portfolio in Q1 2026, its #1066 holding.
  • GTS Securities first reported a position in ResMed in Q4 2023 and has held it in 8 quarters since.
  • GTS Securities's ResMed position peaked at $3.84M in Q4 2023.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.